Quoin Pharmaceuticals Stock (NASDAQ: QNRX) stock price, news, charts, stock research, profile.
Open | $0.630 |
Close | - |
Volume / Avg. | 41.320K / 608.902K |
Day Range | 0.603 - 0.650 |
52 Wk Range | 0.604 - 110.419 |
Market Cap | $2.322M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 18 |
Short Interest | 0.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Quoin Pharmaceuticals (NASDAQ: QNRX) through any online brokerage.
Other companies in Quoin Pharmaceuticals’s space includes: Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Quoin Pharmaceuticals (NASDAQ: QNRX) was reported by Maxim Group on Friday, March 15, 2024. The analyst firm set a price target for 4.00 expecting QNRX to rise to within 12 months (a possible 539.69% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Quoin Pharmaceuticals (NASDAQ: QNRX) is $0.6253 last updated Today at April 26, 2024 at 2:46 PM EDT.
There are no upcoming dividends for Quoin Pharmaceuticals.
Quoin Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Quoin Pharmaceuticals.
Quoin Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.